Pancreatic cancer is a very challenging type of cancer. About 80% of patients are diagnosed in advanced stage, which makes treatment difficult. Less than 20% of patients are detected before cancer cells have spread, yet treatment often requires highly skilled and complex surgical procedures to safely and effectively remove the cancer. At the Anderson Cancer Center, we have provided a multidisciplinary team with rich experience and cutting-edge technology for pancreatic cancer patients to customize personalized treatment programs for each patient.

World class surgeon: the best choice for localized pancreatic cancer

When pancreatic cancer is confined to the pancreas or only spreads to adjacent areas, surgical resection is one of the effective treatments. Successful surgery can significantly improve patients' chances of survival, but this type of surgery is extremely complex and requires a high level of surgical experience. The surgical expert team at Anderson Cancer Center ranks among the top in the United States, with a leading five-year survival rate for surgical patients in the literature, and a postoperative mortality rate of less than 1%, far below the US average. The length of hospital stay after surgery is also greatly reduced.

Pioneer of pancreatic cancer treatment: innovative treatment methods

Anderson Cancer Center has always been at the forefront of comprehensive treatment of pancreatic cancer. Our expert team has taken the lead in using chemotherapy and radiotherapy for preoperative treatment, bringing more surgical opportunities to patients. At the same time, the Anderson team established a "margin resectable" staging subgroup, allowing more advanced patients to receive combination therapy with multiple therapies. We are also constantly promoting innovation in radiation therapy, such as dose escalation and stereotactic radiation therapy (SBRT), which can protect healthy tissues while accurately attacking cancer cells.

Advanced radiation therapy technology

Radiotherapy is one of the most important methods for the treatment of pancreatic cancer. The radiation oncologists at Anderson Cancer Center have extensive experience in stereotactic radiotherapy and dose escalation. These technologies can accurately concentrate high-dose radiation at the tumor site without harming surrounding healthy tissues. Many of our experts have also led national clinical trials, committed to optimizing the radiotherapy of pancreatic cancer and bringing hope to more patients.

Promote the therapeutic frontier of pancreatic cancer through clinical trials

Anderson Cancer Center has carried out a large number of clinical trials to test innovative treatment schemes for local and metastatic pancreatic cancer. These trials provide cutting-edge treatment options that are difficult to obtain elsewhere, and set a new standard for the treatment of pancreatic cancer. Current clinical trials include research on a variety of new therapies, such as combined chemotherapy, radiotherapy and surgery for the treatment of resectable and marginal resectable pancreatic cancer, the development of more effective programs for inoperable advanced pancreatic cancer, early diagnosis strategies, and new treatment breakthroughs for metastatic pancreatic cancer.

Some clinical trials of pancreatic cancer

Personalized peptide vaccine: preliminary study on safety and feasibility for patients with advanced pancreatic ductal adenocarcinoma.

ATP150/ATP152 combined with Ezabenlimab: preliminary evaluation of KRAS mutant pancreatic ductal adenocarcinoma patients.

Palbociclib and Binimetinib combination therapy: a trial targeting RAS mutant cancers.

ELI-002 7P Immunotherapy: Phase 1/2 clinical trial for KRAS/NRAS mutant pancreatic ductal adenocarcinoma and other solid tumors.

RMC-9805: A multicenter open label study specifically targeting advanced solid tumor patients with KRAS G12D mutation.

IMM-104: A novel dual MEK1/2 inhibitor evaluated for its safety and anti-tumor activity in late stage RAS mutations or metastatic solid tumors.

Anderson Cancer Center is committed to providing advanced treatment for patients with pancreatic cancer. Whether your condition is limited or metastatic, our multidisciplinary team will design personalized treatment plans to help you embark on the path of recovery.